CRL

Charles River Laboratories International, Inc.NYSEHealthcare

$173.89-0.58%ClosedMarket Cap: $8.56B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-25	UBS	—	Neutral	—
2026-02-20	Mizuho	—	Neutral	—
2026-02-20	TD Cowen	—	Buy	—
2026-02-19	Barclays	—	Overweight	—
2026-02-19	Evercore ISI Group	—	Outperform	—
2026-01-16	Citigroup	—	Buy	—
2026-01-13	Evercore ISI Group	—	Outperform	—
2025-12-18	Mizuho	—	Neutral	—
2025-12-15	Barclays	—	Overweight	—
2025-12-15	JP Morgan	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Mon Dec 27	$12.12	$4.13B	5
Wed Dec 27	$13.32	$4.32B	1
Thu Dec 27	$14.07	$4.56B	1
Fri Dec 27	$15.50	$4.65B	1